GGB, how about some reality on the NICE timeline issue.
NICE is in the processing of changing this as we speak. So let us talk old and new,
In the old process the company can submit the NICE application (the scientific evidence) prior to the MHRA approval. Nice will evaluate it and form a draft opinion. But that remains unpublished until the MHRA approval. It is the process of evaluating in advance that allows NICE to sometimes issue the opinion within days of the MHRA approval. But there still is a mandatory period for public review before being final.
In the new process, they are allowing the process to goi public with the review even prior to MHRA approval. The means the final opinion can be prior to MHRA approval but is conditional on approval. Thus allowing the full same day decision.
Either way the evaluation can happen prior to MHRA decision. But either way it starts with the company submission to NICE, which has not happened for NWBO.
Until recently I thought it might well happen. Not that expensive and give NWBO a talking point. Alas with the process now going public I doubt LP will submit it. For some reason LP has an issue with the peasants knowing what she is up to.
“Outstanding shares go over 3B in the process. ;)” Yes, and? NWBO has no debt, no toxic financing, and no institutional overlords. Retail owns the float
— LOL, this is exactly why LP loves such bag holders. Enjoy the endless dilution in pennies! Keep more dry powder, you and other retail will have a fantastic opportunity to own more shares at increasingly lower price in 2026, 2027, and beyond. 3rd gen of bag holders will ultimately be wiped off as well! ;)
Market Data 
Markets 
AI
